Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody ; volume:50 ; number:5 ; day:13 ; month:1 ; year:2023 ; pages:1306-1317 ; date:4.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 5 (13.1.2023), 1306-1317, 4.2023
- Creator
-
Stergiou, N.
Wuensche, T. E.
Schreurs, M.
Mes, I.
Verlaan, M.
Kooijman, E. J. M.
Windhorst, A. D.
Helboe, L.
Vergo, S.
Christensen, S.
Asuni, A. A.
Jensen, A.
Van Dongen, G. A. M. S.
Bang-Andersen, B.
Vugts, D. J.
Beaino, W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06109-3
- URN
-
urn:nbn:de:101:1-2023080921015204573675
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stergiou, N.
- Wuensche, T. E.
- Schreurs, M.
- Mes, I.
- Verlaan, M.
- Kooijman, E. J. M.
- Windhorst, A. D.
- Helboe, L.
- Vergo, S.
- Christensen, S.
- Asuni, A. A.
- Jensen, A.
- Van Dongen, G. A. M. S.
- Bang-Andersen, B.
- Vugts, D. J.
- Beaino, W.
- SpringerLink (Online service)
Other Objects (12)
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Comparison of Monoclonal and Polyclonal Enzyme Immuno Assays for Carcinoembryonic Antigen
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Bispecific antibodies
Bispecific antibodies
Immuno-oncology
Immuno-Oncology
ImmunoMedicine
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Comparison of Monoclonal and Polyclonal Enzyme Immuno Assays for Carcinoembryonic Antigen
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Bispecific antibodies
Bispecific antibodies
Immuno-oncology
Immuno-Oncology
ImmunoMedicine
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
Comparison of Monoclonal and Polyclonal Enzyme Immuno Assays for Carcinoembryonic Antigen
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies
Bispecific antibodies
Bispecific antibodies
Immuno-oncology
Immuno-Oncology
ImmunoMedicine